COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk trimmed its full-year profit and sales forecasts on Wednesday as sales growth ...
Novo narrowed its full-year guidance for the fourth time this year, saying it now expects sales growth within the range of 8% ...
Novo Nordisk lowers its 2025 profit forecast as new CEO Mike Doustdar faces rising competition, leadership changes, and a ...
Investing.com -- Novo Nordisk shares have slipped over 2% premarket on Thursday after the company made an unsolicited bid to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results